A poly(D,L-lactide-co-glycolide) microsphere depot system for delivery of haloperidol

被引:36
作者
Cheng, YH
Illum, L
Davis, SS
机构
[1] Univ Nottingham, Dept Pharmaceut Sci, Nottingham NG7 2RD, England
[2] DanBioSyst UK Ltd, Albert Einstein Ctr, Nottingham NG7 2TN, England
关键词
haloperidol; poly(D; L-lactide-co-glycolide) (PLG); emulsification-solvent evaporation method; controlled release;
D O I
10.1016/S0168-3659(98)00056-X
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Haloperidol-loaded biodegradable poly(D,L-lactide-co-glycolide) (PLG) microspheres, with theoretical mean particle sizes of about 0.8, 2 and 8 mu m, have been successfully prepared by using an emulsification-solvent evaporation method. The effect of various processing parameters such as the content of polymer in dichloromethane, the content of polyvinyl alcohol in the aqueous phase, and the stirring speed of emulsification on the particle size and size distribution of microspheres has been investigated and three optimal procedures suggested. The influence of particle size on drug content and incorporation efficiency of haloperidol-loaded PLG microspheres also has been evaluated. In vitro a linear release of haloperidol from PLG microspheres over an extended period of time without a significant burst effect has been achieved; the time of 50% drug release (T-50%) being around 55 days. The effect of drug content and particle size on the cumulative release of haloperidol from PLG microspheres was also studied together with the reproducibility of drug content and release profile from batch-to-batch with different particle sizes. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:203 / 212
页数:10
相关论文
共 17 条
[1]   SOLVENT SELECTION IN THE PREPARATION OF POLY(DL-LACTIDE) MICROSPHERES PREPARED BY THE SOLVENT EVAPORATION METHOD [J].
BODMEIER, R ;
MCGINITY, JW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1988, 43 (1-2) :179-186
[2]   PREPARATION AND CHARACTERIZATION OF 5-FLUOROURACIL-LOADED MICROPARTICLES AS BIODEGRADABLE ANTICANCER DRUG CARRIERS [J].
BOISDRONCELLE, M ;
MENEI, P ;
BENOIT, JP .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1995, 47 (02) :108-114
[3]  
*BRIT MED ASS ROYA, 1997, BRIT NAT FORM, P164
[4]  
DAVIS JM, 1993, ANTIPSYCHOTIC DRUGS, P183
[5]  
Janicki C. A., 1980, ANAL PROFILES DRUG S, V9, P341
[6]  
JOHNSON DAW, 1993, ANTIPSYCHOTIC DRUGS, P205
[7]   PREPARATION OF POLY(D,L-LACTIDE GLYCOLIDE) NANOPARTICLES OF CONTROLLED PARTICLE-SIZE DISTRIBUTION - APPLICATION OF EXPERIMENTAL-DESIGNS [J].
JULIENNE, MC ;
ALONSO, MJ ;
AMOZA, JLG ;
BENOIT, JP .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (10) :1063-1077
[8]  
KINO S, 1994, Patent No. 10982
[9]   EFFECTS OF PREPARATION CONDITIONS OF CISPLATIN-LOADED MICROSPHERES ON THE IN-VITRO RELEASE [J].
KYO, M ;
HYON, SH ;
IKADA, Y .
JOURNAL OF CONTROLLED RELEASE, 1995, 35 (01) :73-82
[10]   PREPARATION AND CHARACTERIZATION OF BUPIVACAINE-LOADED POLYLACTIDE AND POLYLACTIDE-CO-GLYCOLIDE MICROSPHERES [J].
LECORRE, P ;
LEGUEVELLO, P ;
GAJAN, V ;
CHEVANNE, F ;
LEVERGE, R .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 107 (01) :41-49